||Registry of biomedical companies:
   [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Z] 563 active entries
8FL. Daedong Bldg, 1036-8, Seocho Dong, Seocho Gu,
Seoul, Korea 137-070
Phone: 82 2 536 1035
Fax: 82 2 536 1033
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.
Imagene's goal is to capitalize on its preclinical and regulatory experties by developing new drug candidates that can be used, either alone, or in combination, to successfully manage disease. Through an acticve acquisition, and in-licensing program, the company is builiding a portfolio of promising antibiotics. Late stage clinical development and marketing will be done in cooperation with strategic pharmaceutical partners.
Last update of this entry: before October 1999.